Pure Global AI
Manufacturer profile

BIOSYNEX SA

BrazilFrance3 ANVISA registrations3 unique technical categoriesFeb 25, 2021 – Aug 05, 2024
Verified
3
Total products
3
Technical names
Feb 2021
Earliest registration
Aug 2024
Latest registration
Regulatory footprint
Search BIOSYNEX SA across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
INFLIXIMAB (IFX)
LISA-TRACKER INFLIXIMAB
Class II · Aug 05, 2024
ANTI-INFLIXIMAB (IFX) ANTIBODIES
LISA-TRACKER ANTI-INFLIXIMAB
Class II · Jul 22, 2024
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
BIOSYNEX Autoteste Glúten
Class II · Feb 25, 2021
Most popular products
Products with most registrations
INFLIXIMAB (IFX)
1 registrations
ANTI-INFLIXIMAB (IFX) ANTIBODIES
1 registrations
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA
2 products
MANDALA BRASIL IMPORTACAO E DISTRIBUICAO DE PRODUTO MEDICO HOSPITALAR LTDA
1 products
Top competitors
Companies with the most overlapping products (same technical names)
BODITECH MED INC.
South Korea
3 registrations2 shared products
Shared products
ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
BUHLMANN LABORATORIES AG
Switzerland
2 registrations2 shared products
Shared products
ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
PROGENIKA BIOPHARMA S.L.
Spain
2 registrations2 shared products
Shared products
ANTI-INFLIXIMAB (IFX) ANTIBODIES, INFLIXIMAB (IFX)
VEDALAB
France
2 registrations1 shared products
Shared products
AUTOTESTE PARA ANTICORPO PARA DOENÇA CELÍACA
IMMUNDIAGNOSTIK AG
Germany
1 registrations1 shared products
Shared products
INFLIXIMAB (IFX)
About this profile

Explore comprehensive manufacturer profile for BIOSYNEX SA based in France through Pure Global AI's free Brazil medical device database. This manufacturer has 3 products registered with ANVISA across 3 unique technical categories. Their regulatory history spans from Feb 25, 2021 to Aug 05, 2024.

This page provides detailed insights including 3 recent product registrations including INFLIXIMAB (IFX), 3 most popular products with INFLIXIMAB (IFX) having 1 registrations, 2 registration holders including EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA, and 5 key competitors with BODITECH MED INC. sharing 2 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.